APA

Gane E. J., Shiffman M. L., Etzkorn K., Morelli G., Stedman C. A. M., Davis M. N., Hinestrosa F., Dvory-Sobol H., Huang K. C., Osinusi A., McNally J., Brainard D. M., McHutchison J. G., Thompson A. J. & Sulkowski M. S. (20171004). Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen. : Hepatology (Baltimore, Md.).

Chicago

Gane Edward J, Shiffman Mitchell L, Etzkorn Kyle, Morelli Giuseppe, Stedman Catherine A M, Davis Mitchell N, Hinestrosa Federico, Dvory-Sobol Hadas, Huang K C, Osinusi Anu, McNally John, Brainard Diana M, McHutchison John G, Thompson Alex J and Sulkowski Mark S. 20171004. Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen. : Hepatology (Baltimore, Md.).

Harvard

Gane E. J., Shiffman M. L., Etzkorn K., Morelli G., Stedman C. A. M., Davis M. N., Hinestrosa F., Dvory-Sobol H., Huang K. C., Osinusi A., McNally J., Brainard D. M., McHutchison J. G., Thompson A. J. and Sulkowski M. S. (20171004). Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen. : Hepatology (Baltimore, Md.).

MLA

Gane Edward J, Shiffman Mitchell L, Etzkorn Kyle, Morelli Giuseppe, Stedman Catherine A M, Davis Mitchell N, Hinestrosa Federico, Dvory-Sobol Hadas, Huang K C, Osinusi Anu, McNally John, Brainard Diana M, McHutchison John G, Thompson Alex J and Sulkowski Mark S. Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen. : Hepatology (Baltimore, Md.). 20171004.